| New trends in the interventional treatment of ischaemic heart disease. | |
| | |
MedLine Citation:
|
PMID: 9152665 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Direct revascularization of an ischaemic vascular bed represents an attractive treatment option for patients with coronary artery disease. Coronary artery bypass surgery has been demonstrated to provide both symptomatic improvement and, in certain circumstances, to improve prognosis, while catheter-based techniques offer substantial improvement in symptomatology, with reduced morbidity compared with bypass surgery. Although balloon angioplasty has been associated with lesion success rates approximating to 89%, a number of anatomical substrates have proved refractory to this approach and restenosis remains a significant problem. Newer interventional modalities, such as directional atherectomy, rotablation, transluminal extraction catheterization, laser coronary angioplasty and coronary stenting, all have the potential to offer improved rates of restenosis under specific circumstances. With the exception of stents, most have not been shown to provide an overall improvement in rates of restenosis. Numerous pharmacological agents have also been investigated in an attempt to reduce levels of restenosis. Calcium channel blockers have been assessed in five trials, none of which has demonstrated a conclusive benefit, although meta-analysis of the data generated in these trials has shown a 30% reduction in the likelihood of restenosis associated with their use. More recently, monoclonal antibodies to glycoprotein IIb/IIIa have been linked to a reduction in restenosis. |
| | |
Authors:
|
M A Konstam |
Related Documents
:
|
10149995 - Restenosis rate after percutaneous transluminal coronary angioplasty: a literature over... 7850835 - Indications and use of the palmaz-schatz coronary stent. 14556865 - Evaluation of the association of proximal coronary culprit artery lesion location with ... 21078975 - Exogenously administered secreted frizzled related protein 2 (sfrp2) reduces fibrosis a... 8361195 - Duration of asystolic reperfusion and reperfusate electrolyte composition influence pos... 19165645 - Experience with the impella recovery axial-flow system for acute heart failure at three... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: European heart journal Volume: 18 Suppl B ISSN: 0195-668X ISO Abbreviation: Eur. Heart J. Publication Date: 1997 May |
Date Detail:
|
Created Date: 1997-07-31 Completed Date: 1997-07-31 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8006263 Medline TA: Eur Heart J Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: B16-20 Citation Subset: IM |
Affiliation:
|
Department of Medicine, Tufts University School of Medicine, Boston, MA, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Transluminal, Percutaneous Coronary Atherectomy, Coronary Coronary Artery Bypass Humans Myocardial Ischemia / etiology, mortality, therapy* Recurrence Stents Survival Rate Treatment Outcome |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Treatment of ischaemic heart disease. Role of drugs, surgery and angioplasty in unstable angina pati...
Next Document: Clinical promise of calcium antagonists in the angioplasty patient.